title: Periorbital oedema and epiphora as ocular side effects of imatinib mesylate (Gleevec).
authors.forename: B
authors.initials: B
authors.lastname: Esmaeli
authors.forename: R
authors.initials: R
authors.lastname: Diba
authors.forename: M A
authors.initials: MA
authors.lastname: Ahmadi
authors.forename: H G
authors.initials: HG
authors.lastname: Saadati
authors.forename: M M
authors.initials: MM
authors.lastname: Faustina
authors.forename: T R
authors.initials: TR
authors.lastname: Shepler
authors.forename: M
authors.initials: M
authors.lastname: Talpaz
authors.forename: R
authors.initials: R
authors.lastname: Fraunfelder
authors.forename: M B
authors.initials: MB
authors.lastname: Rios
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D004487:Edema / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D007766:Lacrimal Apparatus Diseases / Q000139:chemically induced*; D009916:Orbital Diseases / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate